- Home
- HPS vs PSNL Comparison
HPS vs PSNL Comparison
Compare HPS & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HPS
- PSNL
- Stock Information
- Founded
- HPS 2003
- PSNL 2011
- Country
- HPS United States
- PSNL United States
- Employees
- HPS N/A
- PSNL N/A
- Industry
- HPS Investment Managers
- PSNL Medical Specialities
- Sector
- HPS Finance
- PSNL Health Care
- Exchange
- HPS Nasdaq
- PSNL Nasdaq
- Market Cap
- HPS 451.8M
- PSNL 460.7M
- IPO Year
- HPS N/A
- PSNL 2019
- Fundamental
- Price
- HPS $14.12
- PSNL $3.19
- Analyst Decision
- HPS
- PSNL Strong Buy
- Analyst Count
- HPS 0
- PSNL 5
- Target Price
- HPS N/A
- PSNL $7.80
- AVG Volume (30 Days)
- HPS 58.4K
- PSNL 733.3K
- Earning Date
- HPS 01-01-0001
- PSNL 05-07-2025
- Dividend Yield
- HPS 8.62%
- PSNL N/A
- EPS Growth
- HPS N/A
- PSNL N/A
- EPS
- HPS N/A
- PSNL N/A
- Revenue
- HPS N/A
- PSNL $84,614,000.00
- Revenue This Year
- HPS N/A
- PSNL N/A
- Revenue Next Year
- HPS N/A
- PSNL $27.78
- P/E Ratio
- HPS N/A
- PSNL N/A
- Revenue Growth
- HPS N/A
- PSNL 15.15
- 52 Week Low
- HPS $11.79
- PSNL $1.14
- 52 Week High
- HPS $15.40
- PSNL $7.20
- Technical
- Relative Strength Index (RSI)
- HPS 41.25
- PSNL 42.50
- Support Level
- HPS $13.86
- PSNL $2.86
- Resistance Level
- HPS $14.13
- PSNL $3.40
- Average True Range (ATR)
- HPS 0.37
- PSNL 0.33
- MACD
- HPS -0.03
- PSNL 0.04
- Stochastic Oscillator
- HPS 49.76
- PSNL 40.27
About HPS John Hancock Preferred Income Fund III Preferred Income Fund III
John Hancock Preferred Income Fund III is a closed-end, diversified management investment company. Its investment objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. It seeks to achieve the objectives by investing a majority of its assets in preferred stocks and other preferred securities, including convertible preferred securities. The portfolio composition of the company consists of the U.S. preferred securities, foreign preferred securities, common stocks, corporate bonds, and the short-term investments.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.